lamivudine has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gładysz, A; Knysz, B; Rzeszutko, M; Zalewska, M | 1 |
| Chan, JY; Chan, PK; Johnson, PJ; Leung, NW; Steinberg, JL; Tam, JS; Yeo, W; Zhong, S | 1 |
2 other study(ies) available for lamivudine and Carcinoma, Small Cell
| Article | Year |
|---|---|
Lung cancer as an immune reconstitution disease in an HIV-1 positive man receiving HAART.
Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Small Cell; Fatal Outcome; HIV Seropositivity; Humans; Lamivudine; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Ritonavir; Saquinavir; Zidovudine | 2006 |
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Base Sequence; Breast Neoplasms; Carcinoma, Small Cell; DNA Mutational Analysis; DNA, Viral; Female; Germinoma; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation, Missense; Promoter Regions, Genetic; Reverse Transcriptase Inhibitors; Trans-Activators; Viral Regulatory and Accessory Proteins; Virus Activation | 2000 |